Dr  David Skerrett-Byrne

Dr David Skerrett-Byrne

Honorary Associate Lecturer

School of Environmental and Life Sciences

Career Summary

Biography

Research Focus

My research interests and expertise lie in the application of ever-evolving proteomic and phosphoproteomic technologies and bioinformatics to gain novel insights into complex diseases. My academic and research experience began with a Bachelor of Science (Hons) in Biochemistry and Molecular Biology at University College Dublin, Ireland with a strong focus on mass spectrometry, which sparked my fascination with these technologies and the dynamic diversity of proteomics. I continued my pursuit with a Master of Science in Biotechnology at Ulster University focusing on the role of epigenetics and downstream protein function. Ultimately, this led to a scholarship to undertake a PhD at The University of Newcastle, Australia, under the tutelage of Dr Matt Dun and Professor Phil Hansbro. This was a hugely formative experience and where my passion for mass spectrometry based proteomics exploded. Under the guidance of Dr. Dun, I was instrumental in establishing an advanced proteomics platform at The University of Newcastle, allowing us to apply our expertise to several Priority Research Centres at the University of Newcastle (e.g. Reproductive Science, Cancer Biology, Respiratory), evidenced in high impact publications in field-leading international journals including Molecular & Cellular Proteomics and Leukemia.

Currently I am a Postdoctoral Research Fellow in the Priority Research Centre for Reproductive Sciences under the supervision of Professor Brett Nixon. We are utilising the latest developments in proteomics and bioinformatics, predominately to dissect male gamete development and function, but also with our collaborators, to understand oocyte and ovarian biology. 

Research Esteem

Since starting my Postdoctoral position I have presented my research at two prestigious conferences, The 26th Society for Reproductive Biology Annual Scientific Meeting and The 18th Human Proteome Organization World Congress, receiving a Society for Reproductive Biology ‘Award for Excellence’ for best ECR poster presentation and aAustralasian Proteomics Society Early Career Researcher Travel Award, respectively.

During my PhD I have participated in twelve national and one international conference, including four oral presentations. I have presented my research at several prestigious international institutions including the University of Southern Denmark (Prof. Martin Larsen), Technische Universität München (Prof. Bernhard Kuster), Max Planck Institute für Biochemie (Prof. Matthias Mann), ETH Zürich (Dr. Ben Collins), and University College Dublin (Prof. Stephen Pennington), all made possible through a highly competitive travel grant.

Contribution to the field of research:

Closer to home, I have been able to make important contributions to the medical research community as convenor for the Australian Society for Medical Research Newcastle meeting in 2016-2017, raising >$35,000 to promote the research standing of the Hunter Region. Also, I acted as Sponsorship Liaison for ASMR in 2015-2016, raising >$15,000 in trade displays, and organised the first Newcastle ASMR Science in the Cinema, sparking a dialogue between experts in cancer biology and the general public.

Teaching, Supervision and Mentoring

To promote the use of proteomics at the university I founded the University of Newcastle Proteomics Journal Club. I successfully secured $2,000 of funding over two years for the club which gave us a platform to bring together researchers across faculties and schools at the university, to critically discuss recently published papers, keep up-to-date with the latest techniques and also host workshops on mass spectrometer technology and analysis software such as Proteome Discoverer, MaxQuant, and Perseus.

I have also been fortunate to contribute back to the young researchers of the future by supervising a number of third year and summer scholarship students to successful completion. In Prof Nixon’s research lab, I have been working closely along aside a number of PhD students to assist in developing and carrying out their projects. I have also developed and taught bioinformatical tutorials to undergraduate Biomedical Sciences students (HUBS3302), as well as teaching labs throughout the Biomedical Sciences undergraduate program.

Professional Memberships

  • 2017 – Present: The Human Proteome Organization
  • 2019 – Present: Society for Reproductive Biology
  • 2019 – Present: The Australasian Proteomics Society
  • 2021 – Present: American Society for Biochemistry and Molecular Biology
  • 2017 – 2019: President of the UoN Proteomics Journal Club
  • 2014 – 2018: The Australian Society for Medical Research (ASMR)


Qualifications

  • Doctor of Philosophy, University of Newcastle
  • Bachelor of Science (Honours), University of Dublin - Ireland
  • Master of Science in Biotechnology, University of Ulster

Keywords

  • Epididymal Biology
  • Fertility
  • Parental effects
  • Phosphoproteomics
  • Proteomics
  • Reproductive Health
  • Sperm

Languages

  • Irish (Working)
  • German (Working)
  • English (Mother)

Fields of Research

Code Description Percentage
321503 Reproduction 70
320506 Medical biochemistry - proteins and peptides (incl. medical proteomics) 15
310208 Translational and applied bioinformatics 15

Professional Experience

Teaching appointment

Dates Title Organisation / Department
24/7/2015 - 25/7/2019 Casual Academic School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
Australia

Awards

Award

Year Award
2023 Ken Mitchelhill Young Investigator
Australasian Proteomics Society
2022 Male Contraceptive Initiative ECR Travel Award
Australian Society of Reproductive Biology
2019 Australasian Proteomics Society ECR Travel Award
Australasian Proteomics Society
2017 Jennie Thomas Medical Research Travel Grant
Hunter Medical Research Institute (HMRI)
2017 Australian Society for Medical Research National Conference Student Travel Award
Australian Society for Medical Research (ASMR)
2017 Hunter Cancer Research Alliance Conference Student Sponsorship
Hunter Cancer Research Alliance (HCRA)

Nomination

Year Award
2022 CESE Early Career Researcher Finalist
College of Engineering, Science & Environment, University of Newcastle
2021 David Healy New Investigator Finalist
Society for Reproductive Biology

Recognition

Year Award
2022 Global Talent in Health Industries
Global Talent in Health Industries

Research Award

Year Award
2019 Centre for Reproductive Health, Hudson Institute of Medical Research Award for Excellence for best ECR poster presentation
Society for Reproductive Biology

Teaching

Code Course Role Duration
HUBS2206 Human Biochemistry and Cell Biology
School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
This course provides students with knowledge and understanding of the structure and function of the cells with an emphasis on molecular aspects. It involves integrated learning between the areas of Biochemistry and Molecular Biology. Practical sessions develop core skills that prepare students for a career in laboratory-based research in the biomedical sciences.
Casual Academic 22/2/2016 - 31/12/2017
HUBS3302 Bioinformatics and Functional genomics
School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
The completion of the Human Genome project has resulted in an explosion of molecular information, with the corresponding development of high throughput techniques for sequencing DNA / proteins and looking at their expression profiles in different physiological and pathological situations. New computational tools for seeking, storing and analysing this information have also been developed. The challenge is to use the information stored in databases to solve biological problems and to inform hypothesis generation and future experiments. This course will focus on functional genomics and how to search and use the information using bioinformatics
Casual Lecturer 9/6/2019 - 3/12/2021
HUBS1202 Human Genomics and Biomolecular Analysis
School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
This course represents a blend between fundamental concepts and current issues in molecular medicine. The course focuses on the relationships between structure, function and analysis of Proteins and Nucleic Acids as applied to human disease and provides an introduction to modern concepts of Genomic structure, function and analysis arising from the Human Genome project.
Casual Academic 20/7/2015 - 31/8/2017
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (1 outputs)

Year Citation Altmetrics Link
2022 Skerrett-Byrne D, Jiang CC, Nixon B, Hondermarck H, 'Transcriptomics', Encyclopedia of Cell Biology (Second Edition), Elsevier, Amsterdam, Netherlands 363-371 (2022)
DOI 10.1016/B978-0-12-821618-7.00157-7
Citations Scopus - 2
Co-authors Brett Nixon, Chenchen Jiang, David Skerrett-Byrne, Hubert Hondermarck

Journal article (40 outputs)

Year Citation Altmetrics Link
2024 Chen Y, Roselli S, Panicker N, Brzozowski JS, Skerrett-Byrne DA, Murray HC, Verrills NM, 'Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts.', Proteomics, 24 e2300267 (2024) [C1]
DOI 10.1002/pmic.202300267
Co-authors David Skerrett-Byrne, Heather Murray, Nikki Verrills, Severine Roselli
2024 Richani D, Poljak A, Wang B, Mahbub SB, Biazik J, Campbell JM, et al., 'Oocyte and cumulus cell cooperativity and metabolic plasticity under the direction of oocyte paracrine factors.', Am J Physiol Endocrinol Metab, 326 E366-E381 (2024) [C1]
DOI 10.1152/ajpendo.00148.2023
Citations Scopus - 1
Co-authors David Skerrett-Byrne, Brett Nixon
2024 Mulhall JE, Trigg NA, Bernstein IR, Anderson AL, Murray HC, Sipilä P, et al., 'Immortalized mouse caput epididymal epithelial (mECap18) cell line recapitulates the in-vivo environment.', Proteomics, 24 e2300253 (2024) [C1]
DOI 10.1002/pmic.202300253
Co-authors Heather Murray, David Skerrett-Byrne, John Schjenken, Tessa Lord, Brett Nixon
2024 Smyth SP, Nixon B, Skerrett-Byrne DA, Burke ND, Bromfield EG, 'Building an Understanding of Proteostasis in Reproductive Cells: The Impact of Reactive Carbonyl Species on Protein Fate.', Antioxid Redox Signal, (2024) [C1]
DOI 10.1089/ars.2023.0314
Co-authors Elizabeth Bromfield, Brett Nixon, David Skerrett-Byrne
2024 Duchatel RJ, Jackson ER, Parackal SG, Kiltschewskij D, Findlay IJ, Mannan A, et al., 'PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.', J Clin Invest, 134 (2024) [C1]
DOI 10.1172/JCI170329
Citations Scopus - 1
Co-authors Christopher Dayas, Murray Cairns, Ryan Duchatel, Matt Dun, Lizzie Manning, Heather Murray, Brett Nixon, Susan Hua, David Skerrett-Byrne, Muhammad Jamaluddin
2024 Skerrett-Byrne DA, Stanger SJ, Trigg NA, Anderson AL, Sipila P, Bernstein IR, et al., 'Phosphoproteomic analysis of the adaption of epididymal epithelial cells to corticosterone challenge', ANDROLOGY, [C1]
DOI 10.1111/andr.13636
Co-authors Tessa Lord, David Skerrett-Byrne, Brett Nixon, Matt Dun, Heather Murray
2023 Nixon B, Schjenken JE, Burke ND, Skerrett-Byrne DA, Hart HM, De Iuliis GN, et al., 'New horizons in human sperm selection for assisted reproduction', Frontiers in Endocrinology, 14 (2023) [C1]

Male infertility is a commonly encountered pathology that is estimated to be a contributory factor in approximately 50% of couples seeking recourse to assisted reproductive techno... [more]

Male infertility is a commonly encountered pathology that is estimated to be a contributory factor in approximately 50% of couples seeking recourse to assisted reproductive technologies. Upon clinical presentation, such males are commonly subjected to conventional diagnostic andrological practices that rely on descriptive criteria to define their fertility based on the number of morphologically normal, motile spermatozoa encountered within their ejaculate. Despite the virtual ubiquitous adoption of such diagnostic practices, they are not without their limitations and accordingly, there is now increasing awareness of the importance of assessing sperm quality in order to more accurately predict a male¿s fertility status. This realization raises the important question of which characteristics signify a high-quality, fertilization competent sperm cell. In this review, we reflect on recent advances in our mechanistic understanding of sperm biology and function, which are contributing to a growing armory of innovative approaches to diagnose and treat male infertility. In particular we review progress toward the implementation of precision medicine; the robust clinical adoption of which in the setting of fertility, currently lags well behind that of other fields of medicine. Despite this, research shows that the application of advanced technology platforms such as whole exome sequencing and proteomic analyses hold considerable promise in optimizing outcomes for the management of male infertility by uncovering and expanding our inventory of candidate infertility biomarkers, as well as those associated with recurrent pregnancy loss. Similarly, the development of advanced imaging technologies in tandem with machine learning artificial intelligence are poised to disrupt the fertility care paradigm by advancing our understanding of the molecular and biological causes of infertility to provide novel avenues for future diagnostics and treatments.

DOI 10.3389/fendo.2023.1145533
Citations Scopus - 2Web of Science - 2
Co-authors David Skerrett-Byrne, John Schjenken, Jacinta Martin, Geoffry DeiuliIs, Elizabeth Bromfield, Tessa Lord, Brett Nixon
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.', Cancer research, CAN-23-0186 (2023) [C1]
DOI 10.1158/0008-5472.can-23-0186
Citations Scopus - 7Web of Science - 6
Co-authors David Skerrett-Byrne, Brett Nixon, Ryan Duchatel, Matt Dun
2023 Staudt DE, Murray HC, Skerrett-Byrne DA, Smith ND, Jamaluddin MFB, Kahl RGS, et al., 'Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection (vol 19, 48, 2022)', CLINICAL PROTEOMICS, 20 (2023)
DOI 10.1186/s12014-023-09406-z
Co-authors Brett Nixon, Muhammad Jamaluddin, Heather Murray, Matt Dun, Ryan Duchatel, David Skerrett-Byrne
2023 Germon ZP, Sillar JR, Mannan A, Duchatel RJ, Staudt D, Murray HC, et al., 'Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.', Sci Signal, 16 eabp9586 (2023) [C1]
DOI 10.1126/scisignal.abp9586
Citations Scopus - 5
Co-authors Heather Lee, Heather Murray, David Skerrett-Byrne, Matt Dun, John Schjenken, Brett Nixon, Nikki Verrills, John Aitken, Geoffry DeiuliIs, Ryan Duchatel, Anoop Enjeti
2022 Zhang M, Chiozzi RZ, Skerrett-Byrne DA, Veenendaal T, Klumperman J, Heck AJR, et al., 'High Resolution Proteomic Analysis of Subcellular Fractionated Boar Spermatozoa Provides Comprehensive Insights Into Perinuclear Theca-Residing Proteins.', Front Cell Dev Biol, 10 836208 (2022) [C1]
DOI 10.3389/fcell.2022.836208
Citations Scopus - 11Web of Science - 9
Co-authors Brett Nixon, Elizabeth Bromfield, David Skerrett-Byrne
2022 Smyth SP, Nixon B, Anderson AL, Murray HC, Martin JH, MacDougall LA, et al., 'Elucidation of the protein composition of mouse seminal vesicle fluid.', Proteomics, 22 e2100227 (2022) [C1]
DOI 10.1002/pmic.202100227
Citations Scopus - 9Web of Science - 3
Co-authors David Skerrett-Byrne, John Schjenken, Brett Nixon, Jacinta Martin, Heather Murray
2022 Dunleavy JEM, Dinh DT, Filby CE, Green E, Hofstee P, Pini T, et al., 'Reproductive biology research down under: highlights from the Australian and New Zealand Annual Meeting of the Society for Reproductive Biology, 2021', REPRODUCTION FERTILITY AND DEVELOPMENT, 34 855-866 (2022)
DOI 10.1071/RD22115
Co-authors David Skerrett-Byrne
2022 Perera TRW, Skerrett-Byrne DA, Gibb Z, Nixon B, Swegen A, 'The Future of Biomarkers in Veterinary Medicine: Emerging Approaches and Associated Challenges', ANIMALS, 12 (2022) [C1]
DOI 10.3390/ani12172194
Citations Scopus - 5
Co-authors Brett Nixon, Zamira Gibb, Aleona Swegen, David Skerrett-Byrne
2022 Skerrett-Byrne DA, Anderson AL, Bromfield EG, Bernstein IR, Mulhall JE, Schjenken JE, et al., 'Global profiling of the proteomic changes associated with the post-testicular maturation of mouse spermatozoa', Cell Reports, 41 (2022) [C1]

Spermatozoa acquire fertilization potential during passage through a highly specialized region of the extratesticular ductal system known as the epididymis. In the absence of de n... [more]

Spermatozoa acquire fertilization potential during passage through a highly specialized region of the extratesticular ductal system known as the epididymis. In the absence of de novo gene transcription or protein translation, this functional transformation is extrinsically driven via the exchange of varied macromolecular cargo between spermatozoa and the surrounding luminal plasma. Key among these changes is a substantive remodeling of the sperm proteomic architecture, the scale of which has yet to be fully resolved. Here, we have exploited quantitative mass spectrometry-based proteomics to define the extent of changes associated with the maturation of mouse spermatozoa; reporting the identity of >6,000 proteins, encompassing the selective loss and gain of several hundred proteins. Further, we demonstrate epididymal-driven activation of RHOA-mediated signaling pathways is an important component of sperm maturation. These data contribute molecular insights into the complexity of proteomic changes associated with epididymal sperm maturation.

DOI 10.1016/j.celrep.2022.111655
Citations Scopus - 8Web of Science - 1
Co-authors David Skerrett-Byrne, Elizabeth Bromfield, Brett Nixon, John Schjenken, Matt Dun
2022 Martin JH, Mohammed R, Delforce SJ, Skerrett-Byrne DA, de Meaultsart CC, Almazi JG, et al., 'Role of the prorenin receptor in endometrial cancer cell growth', Oncotarget, 13 587-599 (2022) [C1]
DOI 10.18632/ONCOTARGET.28224
Citations Scopus - 6
Co-authors E Lumbers, Kirsty Pringle, Nikki Verrills, Jacinta Martin, Sarah Delforce, David Skerrett-Byrne
2022 Staudt DE, Murray HC, Skerrett-Byrne DA, Smith ND, Jamaluddin MFB, Kahl RGS, et al., 'Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection', CLINICAL PROTEOMICS, 19 (2022) [C1]
DOI 10.1186/s12014-022-09385-7
Citations Scopus - 2Web of Science - 1
Co-authors Brett Nixon, Nikki Verrills, Matt Dun, Ryan Duchatel, Heather Murray, David Skerrett-Byrne, Muhammad Jamaluddin
2022 Trigg NA, Skerrett-Byrne DA, Martin JH, De Iuliis GN, Dun MD, Roman SD, et al., 'Quantitative proteomic dataset of mouse caput epididymal epithelial cells exposed to acrylamide in vivo', DATA IN BRIEF, 42 (2022)
DOI 10.1016/j.dib.2022.108032
Citations Scopus - 1
Co-authors Geoffry DeiuliIs, Brett Nixon, Matt Dun, David Skerrett-Byrne, Jacinta Martin
2022 Griffin RA, Swegen A, Baker MA, Ogle RA, Smith N, Aitken RJ, et al., 'Proteomic analysis of spermatozoa reveals caseins play a pivotal role in preventing short-term periods of subfertility in stallions .', Biol Reprod, 106 741-755 (2022) [C1]
DOI 10.1093/biolre/ioab225
Citations Scopus - 5Web of Science - 4
Co-authors Zamira Gibb, Aleona Swegen, John Aitken, Roisin Griffin, David Skerrett-Byrne, Mark Baker
2021 Cafe SL, Skerrett-Byrne DA, De Oliveira CS, Nixon B, Oatley MJ, Oatley JM, Lord T, 'A regulatory role for CHD4 in maintenance of the spermatogonial stem cell pool', STEM CELL REPORTS, 16 1555-1567 (2021) [C1]
DOI 10.1016/j.stemcr.2021.04.003
Citations Scopus - 9Web of Science - 6
Co-authors Tessa Lord, Brett Nixon, David Skerrett-Byrne
2021 Nixon B, Anderson AL, Bromfield EG, Martin JH, Cafe SL, Skerrett-Byrne DA, et al., 'Post-testicular sperm maturation in the saltwater crocodile Crocodylus porosus: assessing the temporal acquisition of sperm motility', REPRODUCTION FERTILITY AND DEVELOPMENT, 33 530-539 (2021) [C1]
DOI 10.1071/RD20204
Citations Scopus - 8Web of Science - 8
Co-authors Matt Dun, Brett Nixon, David Skerrett-Byrne, Geoffry DeiuliIs, Elizabeth Bromfield, Jacinta Martin
2021 Cafe SL, Nixon B, Ecroyd H, Martin JH, Skerrett-Byrne DA, Bromfield EG, 'Proteostasis in the Male and Female Germline: A New Outlook on the Maintenance of Reproductive Health', FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 9 (2021) [C1]
DOI 10.3389/fcell.2021.660626
Citations Scopus - 10Web of Science - 5
Co-authors Jacinta Martin, David Skerrett-Byrne, Brett Nixon, Elizabeth Bromfield
2021 Murray HC, Enjeti AK, Kahl RGS, Flanagan HM, Sillar J, Skerrett-Byrne DA, et al., 'Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia', LEUKEMIA, 35 1782-1787 (2021)
DOI 10.1038/s41375-020-01050-y
Citations Scopus - 22Web of Science - 15
Co-authors Matt Dun, Heather Murray, Anoop Enjeti, Nikki Verrills, Gough Au, Brett Nixon, David Skerrett-Byrne
2021 Skerrett-Byrne DA, Bromfield EG, Murray HC, Jamaluddin MFB, Jarnicki AG, Fricker M, et al., 'Time-resolved proteomic profiling of cigarette smoke-induced experimental chronic obstructive pulmonary disease', Respirology, 26 960-973 (2021) [C1]

Background and objective: Chronic obstructive pulmonary disease (COPD) is the third leading cause of illness and death worldwide. Current treatments aim to control symptoms with n... [more]

Background and objective: Chronic obstructive pulmonary disease (COPD) is the third leading cause of illness and death worldwide. Current treatments aim to control symptoms with none able to reverse disease or stop its progression. We explored the major molecular changes in COPD pathogenesis. Methods: We employed quantitative label-based proteomics to map the changes in the lung tissue proteome of cigarette smoke-induced experimental COPD that is induced over 8 weeks and progresses over 12 weeks. Results: Quantification of 7324 proteins enabled the tracking of changes to the proteome. Alterations in protein expression profiles occurred in the induction phase, with 18 and 16 protein changes at 4- and 6-week time points, compared to age-matched controls, respectively. Strikingly, 269 proteins had altered expression after 8 weeks when the hallmark pathological features of human COPD emerge, but this dropped to 27 changes at 12 weeks with disease progression. Differentially expressed proteins were validated using other mouse and human COPD bronchial biopsy samples. Major changes in RNA biosynthesis (heterogeneous nuclear ribonucleoproteins C1/C2 [HNRNPC] and RNA-binding protein Musashi homologue 2 [MSI2]) and modulators of inflammatory responses (S100A1) were notable. Mitochondrial dysfunction and changes in oxidative stress proteins also occurred. Conclusion: We provide a detailed proteomic profile, identifying proteins associated with the pathogenesis and disease progression of COPD establishing a platform to develop effective new treatment strategies.

DOI 10.1111/resp.14111
Citations Scopus - 17Web of Science - 11
Co-authors Tattjhong Haw, Michael Fricker, Peter Wark, Rodney Scott, Elizabeth Bromfield, Brett Nixon, Muhammad Jamaluddin, Matt Dun, Heather Murray, David Skerrett-Byrne
2021 Skerrett-Byrne DA, Trigg NA, Bromfield EG, Dun MD, Bernstein IR, Anderson AL, et al., 'Proteomic dissection of the impact of environmental exposures on mouse seminal vesicle function', Molecular and Cellular Proteomics, 20 (2021) [C1]

Seminal vesicles are an integral part of the male reproductive accessory gland system. They produce a complex array of secretions containing bioactive constituents that support ga... [more]

Seminal vesicles are an integral part of the male reproductive accessory gland system. They produce a complex array of secretions containing bioactive constituents that support gamete function and promote reproductive success, with emerging evidence suggesting these secretions are influenced by our environment. Despite their significance, the biology of seminal vesicles remains poorly defined. Here, we complete the first proteomic assessment of mouse seminal vesicles and assess the impact of the reproductive toxicant acrylamide. Mice were administered acrylamide (25 mg/kg bw/day) or control daily for five consecutive days prior to collecting seminal vesicle tissue. A total of 5013 proteins were identified in the seminal vesicle proteome with bioinformatic analyses identifying cell proliferation, protein synthesis, cellular death, and survival pathways as prominent biological processes. Secreted proteins were among the most abundant, and several proteins are linked with seminal vesicle phenotypes. Analysis of the effect of acrylamide on the seminal vesicle proteome revealed 311 differentially regulated (FC ± 1.5, p = 0.05, 205 up-regulated, 106 downregulated) proteins, orthogonally validated via immunoblotting and immunohistochemistry. Pathways that initiate protein synthesis to promote cellular survival were prominent among the dysregulated pathways, and rapamycin-insensitive companion of mTOR (RICTOR, p = 6.69E-07) was a top-ranked upstream driver. Oxidative stress was implicated as contributing to protein changes, with acrylamide causing an increase in 8-OHdG in seminal vesicle epithelial cells (fivefold increase, p = 0.016) and the surrounding smooth muscle layer (twofold increase, p = 0.043). Additionally, acrylamide treatment caused a reduction in seminal vesicle secretion weight (36% reduction, p = 0.009) and total protein content (25% reduction, p = 0.017). Together these findings support the interpretation that toxicant exposure influences male accessory gland physiology and highlights the need to consider the response of all male reproductive tract tissues when interpreting the impact of environmental stressors on male reproductive function.

DOI 10.1016/j.mcpro.2021.100107
Citations Scopus - 18Web of Science - 9
Co-authors David Skerrett-Byrne, Matt Dun, John Schjenken, Brett Nixon, Elizabeth Bromfield, Tessa Lord, John Aitken
2021 Skerrett-Byrne DA, Anderson AL, Hulse L, Wass C, Dun MD, Bromfield EG, et al., 'Proteomic analysis of koala (phascolarctos cinereus) spermatozoa and prostatic bodies', Proteomics, 21 (2021) [C1]

The aims of this study were to investigate the proteome of koala spermatozoa and that of the prostatic bodies with which they interact during ejaculation. For this purpose, sperma... [more]

The aims of this study were to investigate the proteome of koala spermatozoa and that of the prostatic bodies with which they interact during ejaculation. For this purpose, spermatozoa and prostatic bodies were fractionated from the semen of four male koalas and analysed by HPLC MS/MS. This strategy identified 744 sperm and 1297 prostatic body proteins, which were subsequently attributed to 482 and 776 unique gene products, respectively. Gene ontology curation of the sperm proteome revealed an abundance of proteins mapping to the canonical sirtuin and 14-3-3 signalling pathways. By contrast, protein ubiquitination and unfolded protein response pathways dominated the equivalent analysis of proteins uniquely identified in prostatic bodies. Koala sperm proteins featured an enrichment of those mapping to the functional categories of cellular compromise/inflammatory response, whilst those of the prostatic body revealed an over-representation of molecular chaperone and stress-related proteins. Cross-species comparisons demonstrated that the koala sperm proteome displays greater conservation with that of eutherians (human; 93%) as opposed to reptile (crocodile; 39%) and avian (rooster; 27%) spermatozoa. Together, this work contributes to our overall understanding of the core sperm proteome and has identified biomarkers that may contribute to the exceptional longevity of koala spermatozoa during ex vivo storage.

DOI 10.1002/pmic.202100067
Citations Scopus - 10Web of Science - 7
Co-authors Elizabeth Bromfield, David Skerrett-Byrne, Matt Dun, Brett Nixon, Geoffry DeiuliIs
2021 Skerrett-Byrne DA, Nixon B, Bromfield EG, Breen J, Trigg NA, Stanger SJ, et al., 'Transcriptomic analysis of the seminal vesicle response to the reproductive toxicant acrylamide', BMC Genomics, 22 (2021) [C1]

Background: The seminal vesicles synthesise bioactive factors that support gamete function, modulate the female reproductive tract to promote implantation, and influence developme... [more]

Background: The seminal vesicles synthesise bioactive factors that support gamete function, modulate the female reproductive tract to promote implantation, and influence developmental programming of offspring phenotype. Despite the significance of the seminal vesicles in reproduction, their biology remains poorly defined. Here, to advance understanding of seminal vesicle biology, we analyse the mouse seminal vesicle transcriptome under normal physiological conditions and in response to acute exposure to the reproductive toxicant acrylamide. Mice were administered acrylamide (25 mg/kg bw/day) or vehicle control daily for five consecutive days prior to collecting seminal vesicle tissue 72 h following the final injection. Results: A total of 15,304 genes were identified in the seminal vesicles with those encoding secreted proteins amongst the most abundant. In addition to reproductive hormone pathways, functional annotation of the seminal vesicle transcriptome identified cell proliferation, protein synthesis, and cellular death and survival pathways as prominent biological processes. Administration of acrylamide elicited 70 differentially regulated (fold-change =1.5 or = 0.67) genes, several of which were orthogonally validated using quantitative PCR. Pathways that initiate gene and protein synthesis to promote cellular survival were prominent amongst the dysregulated pathways. Inflammation was also a key transcriptomic response to acrylamide, with the cytokine, Colony stimulating factor 2 (Csf2) identified as a top-ranked upstream driver and inflammatory mediator associated with recovery of homeostasis. Early growth response (Egr1), C-C motif chemokine ligand 8 (Ccl8), and Collagen, type V, alpha 1 (Col5a1) were also identified amongst the dysregulated genes. Additionally, acrylamide treatment led to subtle changes in the expression of genes that encode proteins secreted by the seminal vesicle, including the complement regulator, Complement factor b (Cfb). Conclusions: These data add to emerging evidence demonstrating that the seminal vesicles, like other male reproductive tract tissues, are sensitive to environmental insults, and respond in a manner with potential to exert impact on fetal development and later offspring health.

DOI 10.1186/s12864-021-07951-1
Citations Scopus - 7Web of Science - 3
Co-authors Tessa Lord, David Skerrett-Byrne, John Aitken, John Schjenken, Brett Nixon, Elizabeth Bromfield
2021 Trigg NA, Skerrett-Byrne DA, Xavier MJ, Zhou W, Anderson AL, Stanger SJ, et al., 'Acrylamide modulates the mouse epididymal proteome to drive alterations in the sperm small non-coding RNA profile and dysregulate embryo development', Cell Reports, 37 (2021) [C1]

Paternal exposure to environmental stressors elicits distinct changes to the sperm sncRNA profile, modifications that have significant post-fertilization consequences. Despite thi... [more]

Paternal exposure to environmental stressors elicits distinct changes to the sperm sncRNA profile, modifications that have significant post-fertilization consequences. Despite this knowledge, there remains limited mechanistic understanding of how paternal exposures modify the sperm sncRNA landscape. Here, we report the acute sensitivity of the sperm sncRNA profile to the reproductive toxicant acrylamide. Furthermore, we trace the differential accumulation of acrylamide-responsive sncRNAs to coincide with sperm transit of the proximal (caput) segment of the epididymis, wherein acrylamide exposure alters the abundance of several transcription factors implicated in the expression of acrylamide-sensitive sncRNAs. We also identify extracellular vesicles secreted from the caput epithelium in relaying altered sncRNA profiles to maturing spermatozoa and dysregulated gene expression during early embryonic development following fertilization by acrylamide-exposed spermatozoa. These data provide mechanistic links to account for how environmental insults can alter the sperm epigenome and compromise the transcriptomic profile of early embryos.

DOI 10.1016/j.celrep.2021.109787
Citations Scopus - 19Web of Science - 8
Co-authors David Skerrett-Byrne, Matt Dun, Brett Nixon, Geoffry DeiuliIs
2021 Nixon B, Anderson AL, Bromfield EG, Martin JH, Lord T, Cafe SL, et al., 'Gross and microanatomy of the male reproductive duct system of the saltwater crocodile Crocodylus porosus', REPRODUCTION FERTILITY AND DEVELOPMENT, 33 540-554 (2021) [C1]
DOI 10.1071/RD20303
Citations Scopus - 6Web of Science - 4
Co-authors David Skerrett-Byrne, Jacinta Martin, Brett Nixon, Tessa Lord, Elizabeth Bromfield, Geoffry DeiuliIs
2021 Trigg NA, Stanger SJ, Zhou W, Skerrett-Byrne DA, Sipilä P, Dun MD, et al., 'A novel role for milk fat globule-EGF factor 8 protein (MFGE8) in the mediation of mouse sperm extracellular vesicle interactions', Proteomics, 21 (2021) [C1]

Spermatozoa transition to functional maturity as they are conveyed through the epididymis, a highly specialized region of the male excurrent duct system. Owing to their transcript... [more]

Spermatozoa transition to functional maturity as they are conveyed through the epididymis, a highly specialized region of the male excurrent duct system. Owing to their transcriptionally and translationally inert state, this transformation into fertilization competent cells is driven by complex mechanisms of intercellular communication with the secretory epithelium that delineates the epididymal tubule. Chief among these mechanisms are the release of extracellular vesicles (EV), which have been implicated in the exchange of varied macromolecular cargo with spermatozoa. Here, we describe the optimization of a tractable cell culture model to study the mechanistic basis of sperm¿extracellular vesicle interactions. In tandem with receptor inhibition strategies, our data demonstrate the importance of milk fat globule-EGF factor 8 (MFGE8) protein in mediating the efficient exchange of macromolecular EV cargo with mouse spermatozoa; with the MFGE8 integrin-binding Arg-Gly-Asp (RGD) tripeptide motif identified as being of particular importance. Specifically, complementary strategies involving MFGE8 RGD domain ablation, competitive RGD-peptide inhibition and antibody-masking of alpha V integrin receptors, all significantly inhibited the uptake and redistribution of EV-delivered proteins into immature mouse spermatozoa. These collective data implicate the MFGE8 ligand and its cognate integrin receptor in the mediation of the EV interactions that underpin sperm maturation.

DOI 10.1002/pmic.202000079
Citations Scopus - 10Web of Science - 4
Co-authors David Skerrett-Byrne, Matt Dun, Geoffry DeiuliIs, Brett Nixon, Elizabeth Bromfield
2020 Liu G, Baird AW, Parsons MJ, Fan K, Skerrett-Byrne DA, Nair PM, et al., 'Platelet activating factor receptor acts to limit colitis-induced liver inflammation', FASEB JOURNAL, 34 7718-7732 (2020) [C1]
DOI 10.1096/fj.201901779R
Citations Scopus - 13Web of Science - 8
Co-authors David Skerrett-Byrne, Brett Nixon, Simon Keely, Andrea Johns, Bridie Goggins
2020 Nixon B, Cafe SL, Eamens AL, De Iuliis GN, Bromfield EG, Martin JH, et al., 'Molecular insights into the divergence and diversity of post-testicular maturation strategies', Molecular and Cellular Endocrinology, 517 110955-110955 (2020) [C1]
DOI 10.1016/j.mce.2020.110955
Citations Scopus - 15Web of Science - 10
Co-authors Elizabeth Bromfield, Brett Nixon, Matt Dun, David Skerrett-Byrne, Jacinta Martin, Geoffry DeiuliIs
2020 Griffin RA, Swegen A, Baker M, Aitken RJ, Skerrett-Byrne DA, Rodriguez AS, et al., 'Mass spectrometry reveals distinct proteomic profiles in high- And low-quality stallion spermatozoa', Reproduction, 160 695-707 (2020) [C1]

The horse breeding industry relies upon optimal stallion fertility. Conventional sperm assessments provide limited information regarding ejaculate quality and are not individually... [more]

The horse breeding industry relies upon optimal stallion fertility. Conventional sperm assessments provide limited information regarding ejaculate quality and are not individually predictive of fertilizing potential. The aim of this study was to harness mass spectrometry to compare the proteomic profiles of high- and low-quality stallion spermatozoa, with the ultimate goal of identifying fertility biomarker candidates. Extended stallion semen (n = 12) was fractionated using Percoll density gradients to isolate low-quality and high-quality sperm populations. Motility and morphological assessments were carried out, and proteomic analyses was conducted using UHPLC-MS/MS. High-quality spermatozoa recorded higher total (95.2 ± 0.52% vs 70.6 ± 4.20%; P = 0.001) and progressive motilities (43.4 ± 3.42% vs 27.3 ± 4.32%; P = 0.05), and a higher proportion of morphologically normal cells (50.2 ± 4.34% vs 38.8 ± 2.72%; P = 0.05). In total, 1069 proteins were quantified by UHPLC-MS/MS, of which 22 proteins were significantly more abundant in the high-quality sperm population (P = 0.05). A-kinase anchor protein 4 (AKAP4) and Hexokinase 1 (HK1) were considered possible biomarker candidates and their differential expression was confirmed by immunoblot. Protein expression was significantly correlated with total (AKAP4 R2 = 0.38, P = 0.01; HK1 R2 = 0.46, P = 0.001) and progressive motilities (AKAP4 R2 = 0.51, P = 0.001; HK1 R2 = 0.55, P = 0.01), percentage rapid (AKAP4 R2 = 0.29, P = 0.05; HK1 R2 = 0.58, P = 0.001), straight-line velocity (HK1 R2 = 0.50, P = 0.01) and straightness (HK1 R2 = 0.40, P = 0.01). Furthermore, AKAP4 was highly susceptible to adduction by 4-hydroxynonenal (4HNE), which resulted in a global reduction in the phosphorylation profiles following capacitation. In conclusion, the proteomic profiles of high- and low-quality stallion spermatozoa differ substantially, and proteins such as AKAP4 and HK1 could serve as biomarkers of ejaculate quality.

DOI 10.1530/REP-20-0284
Citations Scopus - 25Web of Science - 22
Co-authors Roisin Griffin, Aleona Swegen, Mark Baker, Zamira Gibb, David Skerrett-Byrne, Brett Nixon, John Aitken
2020 Tamessar CT, Trigg NA, Nixon B, Skerrett-Byrne DA, Sharkey DJ, Robertson SA, et al., 'Roles of male reproductive tract extracellular vesicles in reproduction', AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 85 (2020) [C1]
DOI 10.1111/aji.13338
Citations Scopus - 35Web of Science - 19
Co-authors David Skerrett-Byrne, Brett Nixon, Elizabeth Bromfield, John Schjenken
2020 Dun MD, Mannan A, Rigby CJ, Butler S, Toop HD, Beck D, et al., 'Shwachman Bodian Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia', Leukemia, 34 3393-3397 (2020) [C1]
DOI 10.1038/s41375-020-0814-0
Citations Scopus - 9Web of Science - 8
Co-authors Sam Faulkner, Brett Nixon, Matt Dun, Anoop Enjeti, Hubert Hondermarck, Nikki Verrills, Geoffry DeiuliIs, Ryan Duchatel, David Skerrett-Byrne, Heather Murray
2019 Nixon B, De Iuliis GN, Hart HM, Zhou W, Mathe A, Bernstein IR, et al., 'Proteomic profiling of mouse epididymosomes reveals their contributions to post-testicular sperm maturation', Molecular and Cellular Proteomics, 18 S91-S108 (2019) [C1]
DOI 10.1074/mcp.RA118.000946
Citations Scopus - 114Web of Science - 83
Co-authors David Skerrett-Byrne, Andrea Johns, Matt Dun, Geoffry DeiuliIs, Muhammad Jamaluddin, Brett Nixon, Elizabeth Bromfield
2019 Nixon B, Johnston SD, Skerrett-Byrne DA, Anderson AL, Stanger SJ, Bromfield EG, et al., 'Modification of Crocodile Spermatozoa Refutes the Tenet That Post-testicular Sperm Maturation Is Restricted To Mammals', MOLECULAR & CELLULAR PROTEOMICS, 18 S59-S76 (2019) [C1]
DOI 10.1074/mcp.RA118.000904
Citations Scopus - 28Web of Science - 26
Co-authors David Skerrett-Byrne, Elizabeth Bromfield, Jacinta Martin, Matt Dun, Brett Nixon
2018 Jamaluddin MFB, Ko YA, Kumar M, Brown Y, Bajwa P, Nagendra PB, et al., 'Proteomic profiling of human uterine fibroids reveals upregulation of the extracellular matrix protein periostin', Endocrinology, 159 1106-1118 (2018) [C1]

The central characteristic of uterine fibroids is excessive deposition of extracellular matrix (ECM), which contributes to fibroid growth and bulk-type symptoms. Despite this, ver... [more]

The central characteristic of uterine fibroids is excessive deposition of extracellular matrix (ECM), which contributes to fibroid growth and bulk-type symptoms. Despite this, very little is known about patterns of ECM protein expression in fibroids and whether these are influenced by the most common genetic anomalies, which relate to MED12. We performed extensive genetic and proteomic analyses of clinically annotated fibroids and adjacent normal myometrium to identify the composition and expression patterns of ECM proteins in MED12 mutation-positive and mutation-negative uterine fibroids. Genetic sequencing of tissue samples revealed MED12 alterations in 39 of 65 fibroids (60%) from 14 patients. Using isobaric tagged-based quantitative mass spectrometry on three selected patients (n = 9 fibroids), we observed a common set of upregulated (.1.5-fold) and downregulated (,0.66-fold) proteins in small, medium, and large fibroid samples of annotated MED12 status. These two sets of upregulated and downregulated proteins were the same in all patients, regardless of variations in fibroid size and MED12 status. We then focused on one of the significant upregulated ECM proteins and confirmed the differential expression of periostin using western blotting and immunohistochemical analysis. Our study defined the proteome of uterine fibroids and identified that increased ECM protein expression, in particular periostin, is a hallmark of uterine fibroids regardless of MED12 mutation status. This study sets the foundation for further investigations to analyze the mechanisms regulating ECM overexpression and the functional role of upregulated ECM proteins in leiomyogenesis.

DOI 10.1210/en.2017-03018
Citations Scopus - 16Web of Science - 11
Co-authors David Skerrett-Byrne, Hubert Hondermarck, Rodney Scott, Muhammad Jamaluddin, Pradeep Tanwar, Mark Baker, Matt Dun
2018 Degryse S, de Bock CE, Demeyer S, Govaerts I, Bornschein S, Verbeke D, et al., 'Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia (vol 32, pg 788, 2018)', LEUKEMIA, 32 2731-2731 (2018)
DOI 10.1038/s41375-018-0241-7
Co-authors Nikki Verrills, Heather Murray, David Skerrett-Byrne, Matt Dun
2018 Degryse S, De Bock CE, Demeyer S, Govaerts I, Bornschein S, Verbeke D, et al., 'Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia', Leukemia, 32 788-800 (2018) [C1]

Mutations in the interleukin-7 receptor (IL7R) or the Janus kinase 3 (JAK3) kinase occur frequently in T-cell acute lymphoblastic leukemia (T-ALL) and both are able to drive cellu... [more]

Mutations in the interleukin-7 receptor (IL7R) or the Janus kinase 3 (JAK3) kinase occur frequently in T-cell acute lymphoblastic leukemia (T-ALL) and both are able to drive cellular transformation and the development of T-ALL in mouse models. However, the signal transduction pathways downstream of JAK3 mutations remain poorly characterized. Here we describe the phosphoproteome downstream of the JAK3(L857Q)/(M511I) activating mutations in transformed Ba/F3 lymphocyte cells. Signaling pathways regulated by JAK3 mutants were assessed following acute inhibition of JAK1/JAK3 using the JAK kinase inhibitors ruxolitinib or tofacitinib. Comprehensive network interrogation using the phosphoproteomic signatures identified significant changes in pathways regulating cell cycle, translation initiation, mitogen-activated protein kinase and phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/AKT signaling, RNA metabolism, as well as epigenetic and apoptotic processes. Key regulatory proteins within pathways that showed altered phosphorylation following JAK inhibition were targeted using selumetinib and trametinib (MEK), buparlisib (PI3K) and ABT-199 (BCL2), and found to be synergistic in combination with JAK kinase inhibitors in primary T-ALL samples harboring JAK3 mutations. These data provide the first detailed molecular characterization of the downstream signaling pathways regulated by JAK3 mutations and provide further understanding into the oncogenic processes regulated by constitutive kinase activation aiding in the development of improved combinatorial treatment regimens.

DOI 10.1038/leu.2017.276
Citations Scopus - 70Web of Science - 54
Co-authors Matt Dun, David Skerrett-Byrne, Nikki Verrills, Heather Murray
Show 37 more journal articles

Conference (16 outputs)

Year Citation Altmetrics Link
2023 Mabotuwana NS, Skerrett-Byrne DA, Ashour DE, Butel-Simoes L, Mcgee M, Rech L, et al., 'Harnessing novel paracrine factors from the proteomes of cardiac and mesenchymal stem cells to promote repair of the fibrotic heart', EUROPEAN JOURNAL OF HEART FAILURE (2023)
Co-authors Matt Dun, Andrew Boyle, David Skerrett-Byrne, Lucy Murtha
2023 Duchatel R, Jackson E, Parackal S, Sun C, Daniel P, Mannan A, et al., 'EXPLOITING THE GENETIC DEPENDENCY ON PI3K/ MTOR SIGNALING FOR THE TREATMENT OF H3-ALTERED DIFFUSE MIDLINE GLIOMA', NEURO-ONCOLOGY, CANADA, Vancouver (2023)
Co-authors Matt Dun, Susan Hua, David Skerrett-Byrne, Muhammad Jamaluddin, Murray Cairns, Ryan Duchatel, Brett Nixon
2023 Jackson E, Duchatel R, Staudt D, Persson M, Mannan A, Yadavilli S, et al., 'COMBINING ONC201 AND PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA (DMG); THE PRECLINICAL RESULTS UNDERPINNING THE INTERNATIONAL PHASE II CLINICAL TRIAL (NCT05009992).', NEURO-ONCOLOGY, CANADA, Vancouver (2023)
Co-authors Brett Nixon, Matt Dun, David Skerrett-Byrne, Ryan Duchatel
2022 Jackson E, Duchatel R, Persson M, Mannan A, Yadavilli S, Parackal S, et al., 'PRECLINICAL AND CASE STUDY EXAMINATION OF THE COMBINATION OF THE CLPP AGONIST ONC201 WITH THE PI3K/AKT INHIBITOR PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA.', NEURO-ONCOLOGY, Tampa, FL (2022)
Co-authors David Skerrett-Byrne, Brett Nixon, Matt Dun, Ryan Duchatel
2022 Dun MD, Jackson ER, Duchatel RJ, Persson ML, Mannan A, Yadavilli S, et al., 'PRECLINICAL AND CASE STUDY RESULTS UNDERPINNING THE PHASE II CLINICAL TRIAL TESTING THE COMBINATION OF ONC201 AND PAXALISIB FOR THE TREATMENT OF PATIENTS WITH DIFFUSE MIDLINE GLIOMA (NCT05009992)', NEURO-ONCOLOGY (2022)
Co-authors David Skerrett-Byrne, Matt Dun, Ryan Duchatel, Brett Nixon
2021 Coupland KG, Skerrett-Byrne DA, Sorby-Adams AJ, Turner RJ, Spratt NJ, 'Mapping temporal changes in cerebrospinal fluid composition after stroke to identify novel therapeutic targets for future drug discovery', INTERNATIONAL JOURNAL OF STROKE (2021)
Co-authors David Skerrett-Byrne, Neil Spratt, Kirsten Coupland
2021 Jackson E, Duchatel R, Mannan A, Yadavilli S, Persson M, Kearney P, et al., 'Combination of paxalisib and ONC201 for the treatment of diffuse intrinsic pontine glioma', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)
Co-authors David Skerrett-Byrne, Matt Dun, Ryan Duchatel
2021 Barreto DES, Murray H, Skerrett-Byrne D, Kahl R, Duchatel R, Jamaluddin M, et al., 'Phosphoproteomics predicts novel treatment targets for FLT3-ITD+ AML resistant to targeted therapy', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)
Co-authors Muhammad Jamaluddin, David Skerrett-Byrne, Heather Murray
2020 Jackson ER, Duchatel RJ, Mannan A, Douglas A, Skerrett-Byrne DA, Smith N, et al., 'Panelist Invited Speakers', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2020)
DOI 10.1111/ajco.13470
Co-authors Matt Dun, David Skerrett-Byrne
2020 Duchatel RJ, Jackson ER, Mannan A, Staudt D, Skerrett-Byrne DA, Nixon B, et al., 'Targeting phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) and protein kinase C (PKC) activation in diffuse midline glioma (DMG)', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2020)
Co-authors Muhammad Jamaluddin, Brett Nixon, David Skerrett-Byrne, Matt Dun
2020 Staudt D, Kahl R, Skerrett-Byrne D, Murray H, Jamaluddin M, Woldu AS, et al., 'Proteomic and phosphoproteomic profiling of wildtype (-WT and -FL) and mutant FLT3 (-ITD,-D835V/Y, -and ITD/D835V/Y) signaling pathways in acute myeloid leukemia', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2020)
Co-authors David Skerrett-Byrne, Anoop Enjeti, Nikki Verrills, Heather Murray, Muhammad Jamaluddin, Matt Dun
2020 Murray H, Enjeti AK, Kahl R, Flanagan H, Skerrett-Byrne D, Al-Mazi J, et al., 'Phosphoproteomics Uncovers Synergy between DNA-PK and FLT3 Inhibitors in Acute Myeloid Leukaemia', BLOOD, ELECTR NETWORK (2020)
DOI 10.1182/blood-2020-142435
Co-authors Anoop Enjeti, Heather Murray, David Skerrett-Byrne, Matt Dun
2020 Duchatel RJ, Mannan A, Jackson ER, Staudt D, Skerrett-Byrne DA, Jamaluddin MFB, et al., 'PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE (PI3K) INHIBITION DRIVES PROTEIN KINASE C ACTIVATION (PKC) IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', NEURO-ONCOLOGY (2020)
Co-authors Matt Dun, David Skerrett-Byrne, Muhammad Jamaluddin
2019 Duchatel RJ, Jackson ER, Staudt D, Skerrett-Byrne DA, Jamaluddin MFB, Germon Z, et al., 'Keynote Speakers', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2019)
DOI 10.1111/ajco.13253
Co-authors David Skerrett-Byrne, Muhammad Jamaluddin, Matt Dun
2018 Mclachlan T, Murray H, Skerrett-Byrne D, Dubois O, Withers K, Verrills N, Dun M, 'Molecular Characterization of Treatment Resistance in FLT3 Mutant Pediatric Acute Myeloid Leukemia', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
Co-authors Matt Dun, Heather Murray, David Skerrett-Byrne, Nikki Verrills
2016 Sillar J, Murray H, Al Mazi J, Skerrett-Byrne D, Kahl R, Flanagan H, et al., 'QUANTITATIVE, HIGH-RESOLUTION PROTEOMICS FOR A SYSTEMS BIOLOGICAL ANALYSIS OF ACUTE MYELOID LEUKEMIA', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2016)
Co-authors Heather Murray, Matt Dun, Anoop Enjeti, David Skerrett-Byrne, Hubert Hondermarck
Show 13 more conferences

Other (11 outputs)

Year Citation Altmetrics Link
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.22892044
Co-authors Ryan Duchatel, David Skerrett-Byrne, Matt Dun
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.22892044.v1
Co-authors Ryan Duchatel, David Skerrett-Byrne, Matt Dun
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.22892047
Co-authors Ryan Duchatel, David Skerrett-Byrne, Matt Dun
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.22892047.v1
Co-authors Ryan Duchatel, David Skerrett-Byrne, Matt Dun
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.c.6651055
Co-authors Ryan Duchatel, David Skerrett-Byrne, Matt Dun
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.c.6651055.v1
Co-authors Ryan Duchatel, Matt Dun, David Skerrett-Byrne, Brett Nixon
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.23683824
Co-authors Ryan Duchatel, David Skerrett-Byrne, Matt Dun
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.23683824.v1
Co-authors Ryan Duchatel, David Skerrett-Byrne, Matt Dun
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.23683827
Co-authors Ryan Duchatel, David Skerrett-Byrne, Matt Dun
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.23683827.v1
Co-authors Matt Dun, David Skerrett-Byrne, Ryan Duchatel
2023 Jackson ER, Duchatel RJ, Staudt DE, Persson ML, Mannan A, Yadavilli S, et al., 'Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma', American Association for Cancer Research (AACR) (2023)
DOI 10.1158/0008-5472.c.6651055.v2
Co-authors David Skerrett-Byrne, Matt Dun, Ryan Duchatel
Show 8 more others

Preprint (3 outputs)

Year Citation Altmetrics Link
2023 Duchatel R, Jackson E, Parackal S, Sun C, Daniel P, Mannan A, et al., 'PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma (2023)
DOI 10.1101/2023.04.17.537256
Co-authors Heather Murray, Lizzie Manning, Murray Cairns, David Skerrett-Byrne, Brett Nixon, Susan Hua, Muhammad Jamaluddin, Ryan Duchatel, Matt Dun
2022 Staudt D, Murray H, Skerrett-Byrne D, Smith N, Jamaluddin M, Kahl RGS, et al., 'High-Throughput Global Phosphoproteomic Profiling Using Phospho Heavy-Labeled-Spiketide FAIMS Stepped-CV DDA (pHASED) (2022)
DOI 10.1101/2022.04.22.489124
Co-authors David Skerrett-Byrne, Matt Dun, Muhammad Jamaluddin
2022 Richani D, Poljak A, Wang B, Mahbub S, Biazik J, Campbell J, et al., 'Oocyte and cumulus cell cooperativity and metabolic plasticity under the direction of oocyte paracrine factors (2022)
DOI 10.1101/2022.09.05.506599
Co-authors David Skerrett-Byrne
Edit

Grants and Funding

Summary

Number of grants 13
Total funding $562,528

Click on a grant title below to expand the full details for that specific grant.


20232 grants / $17,000

HMRI Pilot Scheme$10,000

Funding body: Hunter Medical Research Institute, Infertility and Reproduction Research Program

Funding body Hunter Medical Research Institute, Infertility and Reproduction Research Program
Project Team

Dr David Skerrett-Byrne

Scheme Hunter Medical Research Institute Infertility and Reproduction Research Program ECR/MCR Grant
Role Lead
Funding Start 2023
Funding Finish 2023
GNo
Type Of Funding Internal
Category INTE
UON N

Rod Rickards Fellowship$7,000

Funding body: Australian Academy of Science

Funding body Australian Academy of Science
Project Team

Dr David Skerrett-Byrne

Scheme EMCR Mobility Grant
Role Lead
Funding Start 2023
Funding Finish 2023
GNo
Type Of Funding C1700 - Aust Competitive - Other
Category 1700
UON N

20223 grants / $491,897

Mapping temporal changes in cerebrospinal fluid composition after stroke to identify novel therapeutic targets for future drug discovery$478,771

Funding body: CSL Innovation Pty Ltd

Funding body CSL Innovation Pty Ltd
Project Team Doctor Kirsten Coupland, Professor Neil Spratt, Doctor David Skerrett-Byrne, Renee Turner
Scheme Research Acceleration Initiative
Role Investigator
Funding Start 2022
Funding Finish 2023
GNo G2100633
Type Of Funding C3100 – Aust For Profit
Category 3100
UON Y

Fellowship Accelerator Scheme$7,126

Funding body: College of Engineering, Science and Environment, University of Newcastle

Funding body College of Engineering, Science and Environment, University of Newcastle
Scheme Fellowship Accelerator Scheme
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

Impact Translator Scheme$6,000

Funding body: College of Engineering, Science and Environment, University of Newcastle

Funding body College of Engineering, Science and Environment, University of Newcastle
Project Team

Dr Aleona Swegen, Dr Zamira Gibb

Scheme Impact Translator Scheme
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

20213 grants / $30,649

College of Engineering, Science & Environment Equipment & Infrastructure Investment Scheme$24,149

Funding body: College of Engineering, Science and Environment, University of Newcastle

Funding body College of Engineering, Science and Environment, University of Newcastle
Project Team

Dr Elizabeth Bromfield, Dr David Skerrett-Byrne, Dr Tessa Lord, Professor Brett Nixon

Scheme Equipment and Infrastructure Investment Scheme
Role Investigator
Funding Start 2021
Funding Finish 2021
GNo
Type Of Funding Internal
Category INTE
UON N

Publication costs for submission to the top proteomics journal, Molecular and Cellular Proteomics, manuscript entitled “Proteomic dissection of the impact of environmental exposures on mouse seminal$3,500

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor David Skerrett-Byrne
Scheme Research Grant
Role Lead
Funding Start 2021
Funding Finish 2021
GNo G2100182
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

Lockdown support scheme$3,000

Funding body: College of Engineering, Science and Environment, University of Newcastle

Funding body College of Engineering, Science and Environment, University of Newcastle
Project Team

Dr David Skerrett-Byrne

Scheme Lockdown support scheme
Role Lead
Funding Start 2021
Funding Finish 2021
GNo
Type Of Funding Internal
Category INTE
UON N

20203 grants / $19,301

Mapping changes in cerebrospinal fluid composition after stroke to identify novel therapeutic targets for future drug discovery.$12,162

Funding body: John Hunter Hospital Charitable Trust

Funding body John Hunter Hospital Charitable Trust
Project Team Doctor Kirsten Coupland, Professor Neil Spratt, Doctor David Skerrett-Byrne
Scheme Research Grant
Role Investigator
Funding Start 2020
Funding Finish 2020
GNo G2000282
Type Of Funding C3200 – Aust Not-for Profit
Category 3200
UON Y

Priority Research Centre for Drug Development Equipment Grant$5,139

Funding body: Priority Research Centre for Drug Ddevelopment

Funding body Priority Research Centre for Drug Ddevelopment
Project Team

Dr David Skerrett-Byrne; CI: Dr Shaun Roman

Scheme Equipment Grant
Role Investigator
Funding Start 2020
Funding Finish 2020
GNo
Type Of Funding Internal
Category INTE
UON N

Faculty Output Accelerator Initiative$2,000

Funding body: Faculty of Science | University of Newcastle

Funding body Faculty of Science | University of Newcastle
Project Team

Dr David Skerrett-Byrne ; Prof Brett Nixon

Scheme Faculty Output Accelerator Initiative
Role Lead
Funding Start 2020
Funding Finish 2020
GNo
Type Of Funding Internal
Category INTE
UON N

20191 grants / $300

Australasian Proteomics Society ECR Travel Award$300

Funding body: Australasian Proteomics Society

Funding body Australasian Proteomics Society
Project Team

Professor Brett Nixon

Scheme The Human Proteome Organisation Congress 2019 Awards
Role Lead
Funding Start 2019
Funding Finish 2019
GNo
Type Of Funding Not Known
Category UNKN
UON N

20171 grants / $3,381

Jennie Thomas Medical Research Travel Grant$3,381

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor David Skerrett-Byrne, Professor Phil Hansbro, Professor Matt Dun
Scheme Jennie Thomas Medical Research Travel Grant
Role Lead
Funding Start 2017
Funding Finish 2017
GNo G1701070
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y
Edit

Research Supervision

Number of supervisions

Completed5
Current2

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2023 PhD Defining the Role of the Epididymis in Linking Paternal Exposures to Alteration of Sperm Epigenome PhD (Biological Sciences), College of Engineering, Science and Environment, The University of Newcastle Co-Supervisor
2021 PhD Multiomics Approach towards Identifying Plasma Biomarkers for Early Pregnancy Diagnosis in Mares PhD (Biological Sciences), College of Engineering, Science and Environment, The University of Newcastle Co-Supervisor

Past Supervision

Year Level of Study Research Title Program Supervisor Type
2023 Honours The epididymis: a window into natural tumour protection Biological Sciences, Universtiy of Newcastle Principal Supervisor
2023 PhD Molecular Characterisation of Oncogenic Signalling Networks to Develop Treatment Strategies for Diffuse Intrinsic Pontine Glioma PhD (Medical Biochemistry), College of Health, Medicine and Wellbeing, The University of Newcastle Co-Supervisor
2022 Honours Inhibition of the glucocorticoid receptor to ameliorate the impact of acrylamide on male fertility Biological Sciences, PRC for Reproductive Science, University of Newcastle Principal Supervisor
2021 Honours The Impact of Paternal Heat Stress on the Seminal Vesicle and its Secretions Biological Sciences, PRC for Reproductive Science, University of Newcastle Co-Supervisor
2020 Honours The Seminal Impact of Heat Stress in Reproduction Biological Sciences, Priority Research Centre in Reproductive Science Co-Supervisor
Edit

Research Collaborations

The map is a representation of a researchers co-authorship with collaborators across the globe. The map displays the number of publications against a country, where there is at least one co-author based in that country. Data is sourced from the University of Newcastle research publication management system (NURO) and may not fully represent the authors complete body of work.

Country Count of Publications
Australia 56
Netherlands 17
United States 17
Denmark 9
Switzerland 8
More...
Edit

Dr David Skerrett-Byrne

Position

Honorary Associate Lecturer
School of Environmental and Life Sciences
College of Engineering, Science and Environment

Contact Details

Email david.skerrett-byrne@newcastle.edu.au
Phone (02) 4921 6214
Links Research Networks
Twitter

Office

Room LS4.39
Building Life Sciences
Location Callaghan
University Drive
Callaghan, NSW 2308
Australia
Edit